Letters

Regarding Jeffrey Mervis' article "Many Questions, Few Answers on New NSF Science Centers" (THE SCIENTIST, March 23, 1987, p. 1), I'd like to ask a question or two myself. Does the right hand know what the left hand is doing? Why are we overlooking the fact that the NSF's Industry-University Co operative Research Center Program (IUCR) is an excellent model for the Science and Technology Centers? Why is Mervis raising concerns that have been answered in the course of the 10 years or so that the

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Does the right hand know what the left hand is doing? Why are we overlooking the fact that the NSF's Industry-University Co operative Research Center Program (IUCR) is an excellent model for the Science and Technology Centers? Why is Mervis raising concerns that have been answered in the course of the 10 years or so that the IUCR program has been in operation? Why are we trying to reinvent the wheel when a model exists for such centers? The only problem is that IUCR centers have been overlooked and underfunded by NSF. Why does NSF have such amnesia?

Evaluation methods, importance of industrial role, effect on academic environment, appropriate research focus—these have been studied at the 40 or so Industry-University Cooperatives that have been around for years now. There are plenty of data.

I hope that the three study panels men tioned in Mervis' article have contacted Alex Schwarzkopf of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies